Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Beike Biotechnology Invests in Biomaster, a Japanese Stem Cell Company

publication date: Nov 5, 2009
Shenzhen Beike Biotechnology Co. Ltd. has reached an investment agreement with Biomaster Inc., a Japanese company focused on the use of adipose-based stem cells for plastic surgeries. Beike and two investment companies will own a “significant” share of Biomaster, which will employ the new capital to position itself for an IPO. Financial details were not disclosed. At the same time, Beike will gain access to Biomaster’s technology, which Beike will use in its own clinics in China, Southeast Asia and South America. More details...


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital